000 | 03655nam a22005417a 4500 | ||
---|---|---|---|
008 | 240807s20242024 xxu||||| |||| 00| 0 eng d | ||
022 | _a1878-0938 | ||
024 | _aS1553-8389(24)00463-9 [pii] | ||
040 | _aOvid MEDLINE(R) | ||
099 | _a38719633 | ||
245 | _aMarkedly elevated high-sensitivity troponin and in-hospital mortality after cardiac surgery. | ||
251 | _aCardiovascular Revascularization Medicine. 2024 May 05 | ||
252 | _aCardiovasc Revasc Med. 2024 May 05 | ||
253 | _aCardiovascular revascularization medicine : including molecular interventions | ||
260 | _c2024 | ||
260 | _fFY2024 | ||
260 | _p2024 May 05 | ||
265 | _saheadofprint | ||
265 | _tPublisher | ||
266 | _d2024-08-07 | ||
266 | _z2024/05/08 22:01 | ||
501 | _aAvailable in print through MWHC library: 2002 - present | ||
520 | _aBACKGROUND: High-sensitivity troponin (hsTnI) is correlated with cardiac mortality; however, studies on the relationship of markedly elevated hsTnI with in-hospital mortality after cardiac surgery are sparse. Therefore, we aimed to define this relationship in order to help guide in-hospital, acute management of post-surgical patients. | ||
520 | _aCONCLUSION: Increasing hsTnI level is associated with increasing probability of in-hospital mortality and, therefore, serves as an additional, objective measure of risk to help guide in-hospital clinical management. Copyright © 2024 Elsevier Inc. All rights reserved. | ||
520 | _aMETHODS: We retrospectively analyzed all cardiac surgeries completed at our institution between January 2020 and June 2022 in which a peak hsTnI was noted to be >35x upper limit of normal (ULN = 34 ng/L). The primary outcome was in-hospital death. Subgroup analysis was performed to assess differences between coronary artery bypass grafting (CABG) and other cardiac surgeries. | ||
520 | _aRESULTS: A total of 1382 cases met inclusion criteria. The patients' mean age was 64.8 years and 68.2 % were male. Median peak hsTnI after surgery was 4202 ng/L (interquartile ratio: 2427-7654). Univariate analysis of troponin level with mortality found that for every 1000 ng/L increase in hsTnI, odds of in-hospital death increased by 3.8 % (odds ratio [OR]: 1.038; 95 % confidence interval [CI] 1.027-1.050; p < 0.0001). In a multivariate model, troponin (OR 1.02; 95 % CI 1.01-1.04; p = 0.004) maintained a significant association with in-hospital death. CABG was associated with a lower risk of in-hospital death for any given hsTnI level up to 60,000 ng/L compared to other cardiac surgeries. | ||
546 | _aEnglish | ||
650 | _aIN PROCESS -- NOT YET INDEXED | ||
650 | _zAutomated | ||
651 | _aMedStar Heart & Vascular Institute | ||
651 | _aMedStar Washington Hospital Center | ||
656 | _aAdvanced Cardiac Catheterization Research Fellowship | ||
656 | _aInterventional Cardiology Fellowship | ||
657 | _aJournal Article | ||
700 |
_aAladin, Amer _bMWHC _cInterventional Cardiology Fellowship _dMBChB |
||
700 |
_aBen-Dor, Itsik _bMHVI |
||
700 |
_aBhogal, Sukhdeep _bMHVI |
||
700 |
_aCellamare, Matteo _bMHVI |
||
700 |
_aMerdler, Ilan _bMHVI |
||
700 |
_aReddy, Pavan _bMWHC _cAdvanced Cardiac Catheterization Research Fellowship _dMD |
||
700 |
_aRogers, Toby _bMHVI |
||
700 |
_aSatler, Lowell F _bMHVI |
||
700 |
_aWaksman, Ron _bMHVI |
||
700 |
_aZhang, Cheng _bMHVI |
||
790 | _aReddy P, Cellamare M, Merdler I, Zhang C, Bhogal S, Aladin AI, Ben-Dor I, Satler LF, Rogers T, Waksman R | ||
856 |
_uhttps://dx.doi.org/10.1016/j.carrev.2024.05.005 _zhttps://dx.doi.org/10.1016/j.carrev.2024.05.005 |
||
942 |
_cART _dArticle |
||
999 |
_c14440 _d14440 |